Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1097630

Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs


Rezakovic, Saida; Pastar, Zrinjka; Kostovic, Kresimir
Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs // Inflammation & Allergy-Drug Targets, 13 (2014), 4; 241-248 doi:10.2174/1871528113666140717113358 (međunarodna recenzija, članak, ostalo)


CROSBI ID: 1097630 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs

Autori
Rezakovic, Saida ; Pastar, Zrinjka ; Kostovic, Kresimir

Izvornik
Inflammation & Allergy-Drug Targets (1871-5281) 13 (2014), 4; 241-248

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo

Ključne riječi
Cutaneous Adverse Drug Reactions, Antituberculosis Drugs

Sažetak
Multidrug antituberculosis regimen is associated with diverse clinical patterns of cutaneous adverse drug reactions (CADR), ranging from mild and moderate such as pruritus, maculopapular exanthems, lichenoid eruptions, fixed drug eruptions and urticaria to severe and even life threatening ones like acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These adverse reactions to antituberculosis drugs are commonly observed adverse events. This is of particular importance for high HIV prevalence settings and developing countries where tuberculosis is common infection resulting in higher occurrence rate of these reactions. There is still significant heterogenity in definition and classification of CADR, as well as diversity in treatment modalities following adverse reactions and rechallenge management. The aim of this review is to discuss clinical presentation, occurrence of CADR caused by antituberculosis drugs, to identify risk factors for intolerance of the standard therapy as well as to draw attention to importance of multi-disciplinary approach, early detection, prompt diagnosis and in time management of antituberculosis drugs associated CADR. CADR can cause significant treatment interruption and alteration, resulting in increased risk of treatment failure, drug resistance, relapses and increased risk of complications including even lethal outcome. Finally, it can be concluded that it is of great importance to identify the best possible treatment and preventive regimens in order to enable continuity of the antituberculosis therapy to the full extent.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Profili:

Avatar Url Krešimir Kostović (autor)

Avatar Url Zrinjka Paštar (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Rezakovic, Saida; Pastar, Zrinjka; Kostovic, Kresimir
Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs // Inflammation & Allergy-Drug Targets, 13 (2014), 4; 241-248 doi:10.2174/1871528113666140717113358 (međunarodna recenzija, članak, ostalo)
Rezakovic, S., Pastar, Z. & Kostovic, K. (2014) Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs. Inflammation & Allergy-Drug Targets, 13 (4), 241-248 doi:10.2174/1871528113666140717113358.
@article{article, author = {Rezakovic, Saida and Pastar, Zrinjka and Kostovic, Kresimir}, year = {2014}, pages = {241-248}, DOI = {10.2174/1871528113666140717113358}, keywords = {Cutaneous Adverse Drug Reactions, Antituberculosis Drugs}, journal = {Inflammation and Allergy-Drug Targets}, doi = {10.2174/1871528113666140717113358}, volume = {13}, number = {4}, issn = {1871-5281}, title = {Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs}, keyword = {Cutaneous Adverse Drug Reactions, Antituberculosis Drugs} }
@article{article, author = {Rezakovic, Saida and Pastar, Zrinjka and Kostovic, Kresimir}, year = {2014}, pages = {241-248}, DOI = {10.2174/1871528113666140717113358}, keywords = {Cutaneous Adverse Drug Reactions, Antituberculosis Drugs}, journal = {Inflammation and Allergy-Drug Targets}, doi = {10.2174/1871528113666140717113358}, volume = {13}, number = {4}, issn = {1871-5281}, title = {Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs}, keyword = {Cutaneous Adverse Drug Reactions, Antituberculosis Drugs} }

Časopis indeksira:


  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font